🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
100 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

380 mg
📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 380mg

Other Ingredients

Gelatin Magnesium Stearate Silica

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take one capsule one to two times per day with water or as recommended by your healthcare provider.

⚠️ Warnings & Precautions

Warning: For adults only. Keep out of reach of children.

Do not take this product if you are pregnant or nursing. Consult your healthcare provider before using this or any product if you are taking medication or have a medical condition.

Discontinue use if you experience oral discomfort or skin irritation. Do not use if seal is broken.

🧪 Formulation Notes

Supports relaxation and healthy micro-circulation Traditional health-promoting herb Full Spectrum whole herb formula

Supports relaxation

Full Spectrum Feverfew 380 mg per capsule

Additional Information

Store in a cool, dry place.

Product Details

UPC / SKU 0 87614 11700 3
DSLD Entry Date 2024-02-22
Product Type Botanical
Form Capsule
Brand Swanson
DSLD ID 308557
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
View all evidence for Feverfew →

Compare Similar Products

View all Feverfew products →